Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.6K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

1.2K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

650
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
650
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

589
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

478
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

621
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
621

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

'It works in practice, but does it work in theory?' An important addition to the body of real-world evidence supporting carotid endarterectomy.

Vascular medicine (London, England)·2026
Same author

Repair of Access-Related Femoral Artery Pseudoaneurysms Using Percutaneous Suture-Mediated Closure With Ultrasound-Only Guidance.

JACC. Case reports·2026
Same author

Identifying Patients at Elevated Risk of Stroke After Transcarotid Artery Revascularization

Journal of vascular surgery·2026
Same author

Is 5.5 cm Still the Optimal Size Threshold to Treat AAA in Men? A Contemporary Cost-Utility Analysis.

Annals of surgery·2026
Same author

Use of pharmacologic guideline-directed medical therapy for peripheral artery disease by sex among patients undergoing revascularization.

Journal of vascular surgery·2026
Same author

An International, Multi-Specialty Consensus Document on the Optimal Management of Patients with Internal Carotid Artery Occlusion.

Journal of vascular surgery·2026
Same journal

Association of revascularization strategy with wound healing following toe amputation in chronic limb-threatening ischemia.

Journal of vascular surgery·2026
Same journal

Premature peripheral arterial disease (PAD) is associated with worse outcomes after endovascular peripheral vascular intervention.

Journal of vascular surgery·2026
Same journal

Self-Expandable versus Balloon-Expandable Bridging Stents in Off-the-Shelf Inner Branch Repair: Midterm Results from the INBREED Registry.

Journal of vascular surgery·2026
Same journal

Procedural outcomes and follow-up of endovascular treatment for extracranial carotid artery aneurysms; a systematic review.

Journal of vascular surgery·2026
Same journal

Impact of Insurance Status on Urgency of Presentation and Perioperative Outcomes Following Endovascular Repair of Abdominal Aortic Aneurysms: A Vascular Quality Initiative Analysis.

Journal of vascular surgery·2026
Same journal

Large language models routinely overcode peripheral endovascular procedures relative to professional coders.

Journal of vascular surgery·2026
查看所有相关文章

相关实验视频

Updated: May 5, 2026

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation
09:32

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation

Published on: September 19, 2018

15.3K

全球因大动脉动脉瘤死亡率的变化

Brianna M Krafcik1, David H Stone2, Ming Cai3

  • 1Dartmouth-Hitchcock Medical Center, Heart and Vascular Center, Lebanon, NH; VA Outcomes Group, White River Junction VA Medical Center, White River Junction, VT.

Journal of vascular surgery
|February 26, 2024
PubMed
概括
此摘要是机器生成的。

从1990年到2019年,大动脉动脉瘤死亡人数增加了81.6%,主要是由于全球人口老龄化. 然而,年龄标准化的死亡率下降了18%,显示出风险因素控制的改善,特别是吸烟.

关键词:
大动脉动脉瘤是一个大动脉动脉瘤.高血压是因为高血压.公共卫生 公共卫生吸烟 吸烟 吸烟 吸烟社会经济因素社会经济因素

更多相关视频

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm
00:08

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Published on: August 24, 2019

7.6K
Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model
09:32

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model

Published on: February 23, 2020

6.2K

相关实验视频

Last Updated: May 5, 2026

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation
09:32

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation

Published on: September 19, 2018

15.3K
Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm
00:08

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Published on: August 24, 2019

7.6K
Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model
09:32

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model

Published on: February 23, 2020

6.2K

科学领域:

  • 心血管流行病学心血管流行病学
  • 全球健康趋势 全球健康趋势
  • 血管疾病研究 血管疾病研究

背景情况:

  • 在1990年至2019年期间,与大动脉动脉瘤相关的死亡人数在全球范围内显著增加.
  • 了解驱动这种死亡趋势的人口和风险因素病因至关重要.

研究的目的:

  • 为了研究大动脉动脉瘤死亡率的世俗变化.
  • 分析风险因素 (吸烟,高血压,暴露,高饮食) 对死亡率趋势的影响.
  • 为了检查不同社会人口统计指数 (SDI) 地区的大动脉瘤死亡率的变化.

主要方法:

  • 利用全球疾病负担研究 (GBD) 从1990年到2019年的大动脉动脉瘤死亡数据.
  • 评估年龄特定死亡率和年龄标准化死亡率.
  • 量化了可归因于关键风险因素及其时间变化的死亡百分比.
  • 分析了按SDI地区分层的死亡率趋势.

主要成果:

  • 大动脉动脉瘤死亡率上升了81.6% (1990-2019),远远超过了全因死亡率的增加.
  • 年龄标准化的死亡率下降了18%,这表明尽管人口老龄化,但结果有所改善.
  • 在全球范围内,高血压超过了吸烟,成为主要的危险因素.
  • 随着SDI的增加,观察到较高的死亡率,特别是在SDI水平较低和中等的地区.

结论:

  • 大动脉动脉瘤死亡人数的增加主要归因于全球人口老龄化.
  • 风险因素的修改,特别是减少与吸烟相关的死亡,已经调节了死亡率的上升.
  • 建议扩大血管专业服务,以补充风险因素控制和改善人口健康.